Given that only tumoral PD-L1 expression was identified as a significant factor in the multivariate analysis for survival, we investigated whether specific clinicopathological factors differentially influence PD-L1 expression in the stroma, tumor, and stroma + tumor compartments. Here, CD274 is linked to neoplasm.